Bridgehead Communications

Noom

Behaviour-change weight-loss & GLP-1 companion app

Nutrition & metabolic health

Noom is a US-based mobile app that combines cognitive-behavioural coaching and food logging with, since 2023, prescription GLP-1 weight-loss medication support.

The read

Noom has repositioned from a pure CBT-based weight-loss app into a broader GLP-1-era health company, offering medication support and hormone-therapy products alongside its original habit-change programme. In September 2025 it launched a free "microhabits" tier, followed in October 2025 by AI-powered features.

In April 2026 it completed the acquisition of Tailor Made Compounding, a compounding pharmacy, giving it direct control over production of its compounded GLP-1 and hormone-therapy medications. Geoff Cook, appointed CEO in July 2023, succeeded co-founder Saeju Jeong, who remains executive chairman.

The Bridgehead view

Noom's shift from selling behaviour change to manufacturing its own GLP-1 supply shows the whole weight-loss-app category re-platforming around drug distribution rather than psychology, a pivot that raises the regulatory and supply-chain stakes far beyond a typical consumer app.

Work with us

Building a consumer health brand?

We run PR for companies in this market: from category launches and funding announcements to regulatory communications and the press cycle that comes with selling directly to consumers, employers or insurers.

Working across health, insurance or benefits?

We advise insurers, employers and benefits providers on reputation, policy engagement and communications that understand the sector.

The firm that knows health-tech

We map this sector because
we represent it.

Whether you build consumer health technology or work across the insurers, employers and providers who buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.